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SUMMARY
 
Clinical manifestations of pulmonary tuberculosis (TB) may depend on a complex interaction between
the host and the pathogen. Clinical outcomes of pulmonary tuberculosis are variable, ranging from
asymptomatic lifelong infection to parenchymal lung destruction, resulting in cavitary lesions. To inves-
tigate the hypothesis that local cellular immune response may affect presentation and outcome in
tuberculosis, we performed bronchoalveolar lavage (BAL) in lung segments affected by cavitary and
non-cavitary tuberculosis. We then correlated the type of cellular response at the level of the involved
lung segments with clinical evolution in terms of cavity formation. We found alveolar lymphocytosis in
patients with both cavitary and non-cavitary pulmonary tuberculosis, with increased CD4
 
+
 
 lymphocytes
in patients with non-cavitary pulmonary tuberculosis. A predominant Th1 immune response has been
observed in non-cavitary patients, while cavitary involved segments exhibit the presence of Th2 lym-
phocyte subsets. These data, while confirming the importance of Th1-type CD4
 
+
 
 cells and IFN-
 
g
 
  in effec-
tive cellular immunity in active pulmonary tuberculosis, also suggest that the presence of Th2
lymphocytes may contribute to tissue necrosis phenomena associated with cavitary evolution of pul-
monary tuberculosis. Our observations indicate the importance of the type of local immune response at
the site of disease in the development of different clinical characteristics and outcome in pulmonary
tuberculosis.
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INTRODUCTION
 
Tuberculosis (TB) is a granulomatous disorder caused by 
 
Myco-
bacterium tuberculosis
 
, in which the precise clinical manifesta-
tions result probably from a complex interaction between the host
and the pathogen [1].
 
M. tuberculosis
 
 infections can lead to a broad range of clinical
outcomes, from asymptomatic lifelong infection to progressive
primary tuberculosis, to disease reactivation with pulmonary infil-
trates and often parenchymal lung destruction resulting in cavi-
tary lesions. Although interstrain virulence differences among 
 
M.
tuberculosis
 
 isolates may drive the outcome after initial infection,
the type of active disease that develops is dictated generally by
the state of the host immune system.
 
M. tuberculosis
 
, in immunocompetent subjects, induces an
early and late immune response that ultimately destroys most
tubercle bacilli and usually prevents development of clinical dis-
ease. Whereas the early response is characterized by an influx of
phagocytic cells, mainly macrophages, that provide a first line of
defence against mycobacteria in co-operation with other immune
cells, the late response is dependent on the acquisition of CD4
 
+
 
 T
cell-mediated immunity and characterized by granuloma forma-
tion consisting of epithelioid and multi-nucleated giant cells [2,3].
CD4
 
+
 
 T lymphocytes are recognized to be the major effector
cells in cell-mediated immunity in TB [4], although CD4
 
+
 
 lympho-
cytic alveolitis has been detected in many, but not all, patients
with active pulmonary TB [5]. T lymphocytes can be recruited to
the macrophage and stimulate it to inhibit growth of, or kill myco-
bacteria [6] and furthermore cytotoxic T lymphocytes can ingest
macrophages that have engulfed mycobacteria [7].
In recent years, a paradigm for thinking about the functions of
CD4
 
+
 
 T cells and their relationship to the manifestations of dis-
ease has developed initially from observations in the murine
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model and now supported in a variety of human disease, holding
that CD4
 
+
 
 helper T cells can be separated into at least two phe-
notypic classes: Th1 and Th2. These cells derive from so-called
Th0, or null cells, and their differentiation from these precursor
cells may be under the control of several cytokines. Th1 cells are
characterized mainly by their ability to produce the cytokines
interferon (IFN)-
 
g
 
 and interleukin (IL)-2, whereas Th2 cells pro-
duce cytokines such as IL-4, IL-5, IL-10 and IL-13 [8–10]. Exper-
imental investigations in animals have shown that IFN-
 
g
 
 plays a
pivotal role in protective immunity to 
 
M. tuberculosis
 
 [11]. More
recent investigations have associated clinically less advanced
active pulmonary TB, in the absence of cavitary lesions on chest
radiographs, to alveolitis with lymphocytes producing Th1-
associated cytokines such as IFN-
 
g
 
, but not Th2 cytokines [5].
However, there is also evidence of Th2 cytokine production in
peripheral blood mononuclear cells 
 
in vitro
 
 stimulated with myco-
bacterial antigens [12].
In this study we have explored the hypothesis that differences
in tuberculosis outcome, in terms of the development of cavitary
lesions, are associated with different patterns of cellular immune
response at the level of the diseased lung. We have collected bron-
choalveolar lavage (BAL) samples from two well-characterized
homogeneous patient groups with active tuberculosis (exhibiting
cavitary and non-cavitary lung lesions, respectively) to investigate
whether specific T lymphocyte profiles determine cavitary evolu-
tion in pulmonary TB.
 
MATERIALS AND METHODS
 
Patient recruitment criteria
 
Patients admitted to the Monaldi Hospital with suspected pulmo-
nary tuberculosis were approached about the study; suspected
pulmonary tuberculosis was defined as any patient regardless of
HIV status with a chest radiograph suggestive of tuberculosis with
or without symptoms of cough, fever and weight loss. Patients
were considered eligible for this study according to the following
criteria: (1) positive tuberculous skin testing; (2) positive sputum
cultures for tuberculosis; (3) presence by high-resolution com-
puted tomography (HRCT) of cavitary or non-cavitary lesions;
and (4) no evidence of other concurrent diseases. Elegible
patients underwent fibre-bronchoscopy and BAL; both fibre-
bronchoscopy and biological studies were performed in the
Department of ‘Scienze CardioToraciche e Respiratorie – SUN’
located in Monaldi Hospital.
 
Study population
 
Twenty-five subjects, newly diagnosed active pulmonary TB
patients, were approached regarding the study, of whom 18
agreed to participate. Four patients were excluded later based on
negative sputum cultures for 
 
M. tuberculosis
 
. All 14 patients
enrolled had positive tuberculous skin testing, positive sputum
cultures for 
 
M. tuberculosis
 
 and no evidence of other concurrent
diseases. Patient characteristics are reported in Table 1. Seven
normal healthy volunteers were enrolled as a control population.
All patients gave informed consent and the study was approved
by the Institutional Board of the local Ethical Committee.
 
Hrct
 
All patients underwent chest HRCT analysis in the supine
position. HRCT studies were performed on Toshiba Xpress GX
(Toshiba, Japan) and were evaluated for the presence, distribution
and extent of the following signs: miliary nodules; nodules; pan-
lobular and polylobular consolidation; and cavity. HRCT were
reviewed prior to bronchoscopy/BAL by two independent chest
radiologists to define the areas of major involvement.
 
BAL
 
For each subject, BAL was performed with a flexible broncho-
scope with local xylocaine anaesthesia. Three 50-ml aliquots of
sterile saline solution were instilled and subsequently recovered
by gentle suction from radiographically involved segments [13]. In
normal volunteers, the right median lobe was lavaged and the
BAL fluid was coded by number in a blinded fashion. The BAL
fluid was filtered through two layers of sterile cotton gauze to
remove mucus and centrifuged at 1000 r.p.m. for 10 min. Super-
natants were aliquoted and stored frozen.
The alveolar cell population was counted by optic microscope
using a Burker chamber. Cell viability was determined by trypan
blue exclusion. All recovered cells showed 
 
>
 
90% viability. Cell
pellets and supernatants were separated by centrifugation at
1000 r.p.m. for 5 min and two slides prepared by smears were
stained using May–Grunwald–Giemsa in order to obtain cyto-
grams and differential cell counts. We used smears for broncho-
alveolar differential cell counts because of the highest accuracy of
this technique compared to cytospin [14,15].
The BAL cells were washed twice in RPMI-1640 (Boehringer
Mannheim, Mannheim, Germany), resuspended at 10
 
6
 
 cells per
ml in serum-free RPMI and than assessed by FACScan flow
cytometer, as described in the following section.
 
Three-colour flow cytometry analysis
 
BAL cell analysis was performed using a three-colour flow cytof-
luorimeter (Becton Dickinson immunocytometry system, FACS-
can, San Jose, CA, USA) according to the method reported
previously [16,17].
In brief, 100 
 
m
 
l of cellular suspension were incubated in the
dark for 30 min at 4
 
∞
 
C with 20 
 
m
 
l of the following monoclonal
antibodies (MoAb):
CD45
 
PERCP
 
, CD3
 
FITC
 
, CD4
 
PE
 
; CD45
 
PERCP
 
, CD3
 
FITC
 
, CD8
 
PE
 
;
CD45
 
PERCP
 
, CD3
 
FITC
 
, CD19
 
PE
 
; CD45
 
PERCP
 
, CD3
 
FITC
 
, CD16
 
PE
 
;
CD45
 
PERCP
 
, CD3
 
FITC
 
, HLA-DR
 
PE
 
; CD45
 
PERCP
 
, CTR
 
FITC
 
, CTR
 
PE
 
(BD Biosciences, San Jose, CA, USA).
Cells were washed three times with PBS 1% FCS (Boehringer
Mannheim, Germany) and then resuspended in 2 ml of PBS.
Using an acquisition gate on lymphocytes in the side scatter (SSC)
 
versus
 
 fluorescence (Fl)
 
3
 
 (CD45
 
PERCP
 
) dot-plot, we collected 5000
 
Table 1.
 
Demographics of enrolled patients
Total recruited 18
Total eligible 14
Sex
Male 14
Female 0
Age, years
Median 34
Range 25–67
 
Mycobacterium
 
 sputum culture positive (no.) 14
Radiological features (HRTC)
Cavitary lesions 7
Non-cavitary lesions 7
 T lymphocyte profiles and tuberculosis outcomes
 
285
 
© 2003 Blackwell Publishing Ltd, 
 
Clinical and Experimental Immunology
 
, 
 
132
 
:283–288
 
events for each sample. All values were expressed as mean 
 
±
 
 stan-
dard deviation (s.d.) of percentages of cell phenotypes.
 
Flow cytometry for intracellular cytokines
 
Analysis of Th1- and Th2-like populations in BAL was per-
formed utilizing a three-colour flow cytofluorimeter (Becton
Dickinson immunocytometry system, FACScan) according to the
method described elsewhere [18,19], with minor modification. In
brief, two aliquots of 200 
 
m
 
l of BAL lymphoid cells from the two
groups of lung TB patients (cavitary TB, non-cavitary TB) were
used to perform the experiments. BAL fluid was filtered in ster-
ile gauze and then centrifuged; cellular pellets were washed
thrice in PBS 1% FCS and resuspended at the concentration of
1 
 
¥
 
 10
 
6
 
 cells/ml in RPMI-1640 
 
+
 
 10% FCS 
 
+
 
 Pen/Strep (550 IU/
ml) (500 
 
m
 
g/ml) (Boehringer Mannheim, Germany). In the first
aliquot, cells were stimulated 
 
in vitro
 
 by phorbol myristate ace-
tate (PMA) (50 ng/ml) 
 
+
 
 ionomycin (1 
 
m
 
g/ml) (Sigma-Aldrich,
Milan, Italy). To detect intracellular storage of specific Th1/Th2-
associated cytokines, cell secretion was blocked by adding brefel-
din A (5 
 
m
 
g/ml) (Sigma-Aldrich, Italy). Cells were cultured for
6 h at 37
 
∞
 
C 5% CO
 
2
 
.
Subsequently cells were incubated with the monoclonal anti-
body CD4
 
PERCP
 
, fixed and permeabilized by paraformaldehyde
5%/saponin 0·1% (Sigma-Aldrich, Italy).
Each sample was separated into two aliquots. One was incu-
bated with MoAb anti-IFN-
 
g
 
FITC
 
 and IL4-
 
PE
 
, the other with con-
trol mouse isotopic MoAbs (BD Biosciences, San Jose, CA,
USA).
To exclude any dead and contaminating non-CD4
 
+
 
 lympho-
cytes from the analyses, acquisition of data by flow cytometry was
performed selecting an immunological gate on CD4-positive lym-
phocytes on the dot-plot SSC 
 
versus
 
 Fl
 
3
 
(CD4
 
PERCP
 
), acquiring
5000 events for each experiment.
Analysis of the data was carried out by three independent
observers (F.P., A.B., D.D.A) to avoid bias. Percentage results of
Th1-like (CD4
 
+
 
 IFN-
 
g
 
FITC
 
+
 
) and Th2-like (CD4
 
+
 
 IL4
 
PE
 
+
 
) lympho-
cyte subsets were obtained subtracting values acquired on control
samples.
 
Statistical analysis
 
Wilcoxon’s signed-rank test for paired data was applied to the
results. Probability values of 
 
<
 
0·05 were considered significant.
 
RESULTS
 
Differential and absolute cell counts in bronchoalveolar
lavage fluid
 
Patients with tuberculosis exhibited a significant increase in the
number of recovered cells (cavitary: mean 15·08 
 
±
 
 0·9 
 
¥
 
 10
 
6
 
; non-
cavitary: mean 15·9 
 
±
 
 0·55 
 
¥
 
 10
 
6)
 
 compared to normal control
subjects (mean 4·3 
 
±
 
 0·6 
 
¥
 
 10
 
6
 
); no differences were found
between cavitary and non-cavitary patients. A significant
increase in number of lymphocytes as well as neutrophils was
found in patients with TB (both cavitary and non-cavitary) over
normal healthy subjects (
 
P
 
 
 
<
 
 0·05), in parallel with a significant
decrease in alveolar macrophage number. Increase of neutro-
phils has also been observed in cavitary compared to non-
cavitary patients (
 
P
 
 
 
<
 
 0·05); conversely, lymphocytes are
enhanced in non-cavitary compared to cavitary patients
(
 
P
 
 
 
<
 
 0·05). Table 2 summarizes data referring to absolute and dif-
ferential cell counts in BAL fluid.
 
Flow cytofluorimeter analysis of BAL cell pellets
 
Table 3 shows FACScan analysis of lymphocyte subpopulations
retrieved in BAL of subjects with cavitary and non-cavitary TB, as
well as normal healthy subjects as the control population. BAL of
 
Table 2.
 
BAL differential cell count in the involved lobe
Cavitary TB Non-cavitary TB Normal healthy volunteers
BAL recovered (ml) 58 
 
± 
 
7·2 59·7 
 
± 
 
6·7 55·1 
 
± 
 
6·0
Total cells collected 15·08 
 
± 
 
0·9 
 
¥ 
 
10
 
6
 
† 15·9 
 
± 
 
0·55 
 
¥ 
 
10
 
6
 
‡ 4·3 
 
± 
 
0·6 
 
¥ 
 
10
 
6
 
Cells/ml 2·4 
 
± 
 
0·1 
 
¥ 
 
10
 
5
 
† 2·6 
 
± 
 
0·2 
 
¥ 
 
10
 
5
 
‡ 0·5 
 
± 
 
0·18 
 
¥ 
 
10
 
5
 
Macrophages percentage 68·8 
 
± 
 
3·13*† 61·4 
 
± 
 
3·4‡ 87·5 
 
± 
 
1·8
Neutrophils percentage 5·85 
 
± 
 
1·06*† 4 
 
± 
 
0·8‡ 1·6 
 
± 
 
0·5
Eosinophils percentage 0·8 
 
± 
 
0·8 0·5 ± 0·5 0·8 ± 0·4
Lymphocytes percentage 24 ± 2·1*† 30·2 ± 1·5 10·5 ± 2·07
Mean value ± s.d. of cellular components of bronchoalveolar lavage of patients with pulmonary cavitary tuberculosis, pulmonary non-cavitary
tuberculosis and normal healthy voluntaries. *P < 0·05 for cavitary versus non-cavitary; †P < 0·05 for cavitary versus controls; ‡P < 0·05 for non-cavitary
versus controls.
Table 3. BAL T lymphocyte subsets in the involved lobe
Lymphocyte subsets Cavitary TB Non-cavitary TB
Normal healthy
volunteers
CD3% 92·5 ± 1·9 92·2 ± 2·14 91·5 ± 1·37
CD4% 48 ± 2·1* 62·4 ± 2·9 56·1 ± 1·9
CD8% 41·5 ± 1·7*† 24 ± 2·3‡ 35·7 ± 3·01
CD4/CD8 1·15 ± 0·06* 2·6 ± 0·3 1·3 ± 0·15
CD3+ HLA-DR+% 10 ± 2·6† 9·1 ± 2·1 5·1 ± 0·6
CD 19% 0·2 ± 0·2 0·16 ± 0·17 0·1 ± 0·1
CD 16% 3·4 ± 1·7 4·81 ± 1·06 3·1 ± 0·7
Mean value ± s.d. of lymphocyte subsets from bronchoalveolar lavage
of patients with pulmonary cavitary tuberculosis, pulmonary non-cavitary
tuberculosis and normal healthy voluntaries. *P <0·05 for cavitary versus
non-cavitary; †P < 0·05 for cavitary versus controls; ‡P < 0·05 for non-
cavitary versus controls.
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cavitary subjects showed significant enhancement of a percentage
of CD8-positive cells (P < 0·05) over non-cavitary subjects, asso-
ciated with a significant decrease in CD4-positive cells, as well as
the CD4/CD8 ratio (P < 0·05). Patients with cavitary tuberculosis
showed an increased percentage of CD8+ and CD3+ HLA-DR+
(P < 0·05) over normal subjects.
BAL cell pellets from non-cavitary patients exhibited a sig-
nificant increase in the percentage of CD4+, CD3+ HLA-DR+,
but a decrease in CD8+ (P < 0·05) compared to normal sub-
jects. No significant differences for CD3-, CD16- and CD19-
positive cells were found between the three groups of subjects
studied.
Intracellular analysis of Th1/Th2 subsets by flow cytofluorimeter 
in non-cavitary and cavitary TB
CD4 T lymphocytes from BAL of lung segments affected by non-
cavitary pulmonary TB exhibited a predominant type-1 (IFN-g)
response (Fig. 1a).
Figure 2 shows the simultaneous detection of IFN-g and
IL-4 in BAL CD4+ cells from a representative patient with
non-cavitary TB. BAL from this patient shows 41·6% of
IFN-g-producing cells and 3·5% of IL-4-producing cells as well as
3·1% of cells producing both IFN-g and IL-4.
BAL cells collected from radiographically involved cavitary
lesions showed a significant presence of Th2-like lymphocytes
with concurrent detection of a Th1 subset, as well as T lympho-
cytes CD4+ exhibiting both Th1 and Th2 intracellular cytokines
(Fig. 1b). Figure 3 shows the simultaneous detection of IFN-g and
IL-4 in BAL CD4+ cells from a representative patient with cavi-
tary TB. BAL from this patient shows 5·7% of IFN-g-producing
cells and 14·1% of IL-4-producing cells, as well as 2·7% of cells
producing both IFN-g and IL-4.
DISCUSSION
In this study alveolar lymphocytosis in patients with both cavitary
and non-cavitary pulmonary TB has been found. An increased
percentage of CD4+ lymphocytes was present in patients with
non-cavitary pulmonary tuberculosis, but not with cavitary
lesions. A significant increase of neutrophils was demonstrated in
lung segments affected by cavitary disease compared to non-
cavitary lesions. Phenotypic analysis of cells retrieved from pul-
monary segments exhibiting cavitary lesions showed a significant
enhancement in the percentage of CD8-positive lymphocytes,
Fig. 1. Expression of interleukin (IL)-4 and interferon (IFN)-g  in pulmo-
nary tuberculosis patients with and without cavity. The percentages of
BAL CD4+ cells expressing IFN-g (a) and IL-4 (b) are reported. Each dot
represents one individual. Horizontal bar is the mean value.
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Fig. 2. Expression of interleukin (IL)-4 and interferon (IFN)-g in BAL
CD4+ cells from a patient with non-cavitary pulmonary tuberculosis. Flow
cytometric assessment of cell-specific cytokine response in BAL cells was
performed by use of immunofluorescent antibodies against CD4, IFN-g and
IL-4. Depicted is the percentage of CD4+ cells expressing IFN-g and/or
IL-4.
0·5% 0·1%IL-4 IL-4 3·5% 3·1%
41·6%0·5%
Unstimulated StimulatedIFN-g IFN-g
Fig. 3. Expression of interleukin (IL)-4 and interferon (IFN)-g in BAL
CD4+ cells from a patient with cavitary pulmonary tuberculosis. Flow
cytometric assessment of cell-specific cytokine response in BAL cells was
performed by use of immunofluorescent antibodies against CD4, IFN-g
and IL-4. Depicted is the percentage of CD4+ cells expressing IFN-g and/
or IL-4.
0·2% 0·1% 14·1% 2·7%
5·7%0·6%
IL-4 IL-4
Unstimulated StimulatedIFN-g IFN-g
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with a parallel reduction in the CD4/CD8 ratio (P < 0·05) com-
pared to non-cavitary lesions.
We have also explored the percentage of CD3-, CD16- and CD
19-positive cells. This enabled both the exclusion of false-positive
and -negative cells from our measurements and the identification
of the presence of non-lymphocyte related events contaminating
the gated region. No differences were found for CD3-, CD16- and
CD19-positive cells between the two groups of subjects studied.
Using cytofluorimeter flow analysis, the expression of type-1
(IFN-g) and type-2 (IL-4) cytokines in bronchoalveolar lympho-
cytes was also assessed. We have shown a predominant Th1
immune response in patients affected by non-cavitary pulmonary
TB. These results are consistent with experimental investigations
supporting the importance of Th1-type CD4+ cells, IL-12 and IFN-
g in effective local cellular immunity in active pulmonary TB
[11,20–23]. To highlight further the role of Th1 lymphocytes in TB,
other investigations indicate that patients who did not exhibit an
IFN-g-associated lymphocytic alveolitis initially did so later in
their course, and elevated levels of this cytokine were observed as
patients improved clinically [5].
Interestingly, in our experiments we have found the presence
of Th2 lymphocyte subsets at the level of pulmonary segments
radiographically affected by cavitary TB. To our knowledge, this is
the first observation correlating cavitary pulmonary TB with a
type 2 response at the site of the disease. However, we failed to
find detectable levels of IL-4 in supernatant of the bronchoalve-
olar fluid after 20-fold concentration by means of AMICON con-
centrators, measured by enzyme-linked immunosorbent assay
(ELISA; R&D Systems, Minneapolis, MN, USA) (data not
shown).
In agreement with our results, other investigations indicate
that IL-4 may not be detectable in culture supernatants [24,25]
because production of IL-4 splice variants, or binding of secreted
IL-4 to soluble or cellular receptors, interferes with this assay [26].
To override this problem and to allow for cell-specific analysis of
Th status in tuberculosis we used flow cytometric detection of
intracellular cytokine expression, which is a reliable method as it
is unaffected by the natural release of cytokine inhibitors or
receptors [19].
Other studies have already documented the presence of Th-2
lymphocytes in peripheral blood of patients with TB. Sourcel and
co-workers [12], stimulating in vitro peripheral blood mononu-
clear cells with mycobacterial antigens, have indeed found that
patients with tuberculosis have an increased proliferation of cells
secreting IL-4 but not IFN-g when compared with cells from
healthy subjects. Other investigations have indicated that patients
with tuberculosis have a Th2 response in peripheral blood,
whereas tuberculin-positive subjects have a Th1-type response
[27]. More recently, Van Crevel and co-workers have demon-
strated a marked increase of IL-4 production in circulating T lym-
phocytes from cavitary pulmonary TB [28]. These results,
although not performed at the site of disease, are in agreement
with our observation that pulmonary cavitary TB exhibits a pre-
dominant Th2 response.
Consistent with other infectious disease such as leprosy and
leishmaniasis, where Th-2 lymphocytes have been associated with
poor outcome [28], release of type-2 cytokines IL-4 and IL-5 has
also been found at the site of disease depending on the severity of
tuberculosis [29,30].
According to several observations, the presence of Th2 lym-
phocytes could be involved in tissue necrosis phenomena that
characterize cavitary pulmonary TB. Indeed, studies report the
involvement of IL-4 in tissue damage in mycobacterial infection
in mice [31]. Separate investigations indicate that, while TNF-a
exhibits beneficial effects in term of enhancing mycobacterium
tuberculosis control in the presence of a predominant Th1
response, a combination of Th2 cytokines and TNF-a causes a sig-
nificant increase in tissue damage [32–34].
Our findings support these observations further and indicate
the importance of the type of local immune response in presen-
tation and clinical outcome of TB. Although additional studies
are needed, our investigations suggest a possible implication for a
Th2-type response in the tissue necrosis phenomenon related to
cavitary evolution of TB. A better understanding of the role of
cytokines in influencing the balance between protective immunity
and immunopathology may provide further insight into both crit-
ical mechanisms underlying the variability of pulmonary TB
pathology and new therapeutic approaches in TB treatment.
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